Anebulo Pharmaceuticals ANEB Cash Flow Statement (2020-2025)

OTC ANEB
$0.31 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT
Reported Financials

Anebulo Pharmaceuticals Quarterly Cash Flow Statement

Periods 23 quarters
Latest Dec 2025

Anebulo Pharmaceuticals reported cash from operations of -$1.31M and free cash flow of -$1.31M for the quarter ended Dec 2025, up 6.6% year over year. This cash flow statement covers 23 quarters of results from Jun 2020 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income
-0.56M-29.11M-1.55M-1.07M-1.88M-2.32M-2.61M-3.83M-2.80M-2.50M-2.48M-2.72M-1.65M-1.35M-2.20M-2.46M-1.68M-2.16M-2.16M-2.00M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.06M0.06M0.06M0.06M0.25M0.02M0.02M0.02M
Share-based CompensationStock Comp.
0.05M0.12M0.03M0.09M0.13M0.23M0.21M0.20M0.20M0.18M0.21M0.20M0.20M0.20M0.30M0.60M0.30M0.34M0.24M0.20M
Change in Working Capital
Change in Account PayablesChange Payables
0.00M0.03M0.38M-0.45M0.04M0.30M-0.11M0.07M0.22M-0.04M0.03M-0.25M0.07M-0.23M0.10M0.03M0.15M-0.20M0.38M-0.05M
Change in Accured ExpensesChange Accured Exp.
0.15M-0.08M-0.02M-0.11M0.00M0.13M0.04M0.85M-0.11M-0.39M-0.38M0.54M-0.07M-0.52M0.21M0.24M-0.44M0.15M0.09M0.57M
Change in Other Operating AssetsOther Assets Change
0.56M1.08M-0.38M-0.34M-0.25M0.33M-0.43M-0.07M-0.27M0.15M0.10M-0.36M0.05M0.19M-0.35M0.27M0.19M-0.34M-0.03M-0.04M
Other Working Capital ChangesOther WC Changes
-0.56M-1.08M0.38M0.34M0.25M-0.33M0.43M0.07M0.27M-0.15M-0.10M0.36M-0.05M-0.19M0.35M-0.27M-0.19M0.34M0.03M0.04M
Cash from OperationsCash from Ops.
-0.83M-3.50M-0.78M-1.20M-1.46M-2.00M-2.03M-2.61M-2.19M-2.85M-2.73M-1.81M-1.50M-2.05M-1.69M-1.41M-1.60M-1.65M-1.27M-1.31M
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued
6.70M
Shares Repurchased
0.25M
Net Shares Issued and RepurchasedNet Shares Issued
6.45M
Net Equity Issued and RepurchasedNet Equity Issued
6.45M
Other financing activitiesOther financing
-0.07M
Cash from Financing ActivitiesCash from Financing
20.18M6.70M-0.25M-0.07M-0.12M
Additional items
Change in Cash
0.83M16.68M-0.78M-1.20M-1.46M-2.00M4.67M-2.86M-2.19M-2.92M-2.73M-1.88M-1.50M-2.05M-1.69M13.59M-1.72M-1.65M-1.27M-1.31M
Ending Cash Balance
3.31M19.99M19.21M18.01M16.55M14.55M19.21M16.36M14.16M11.25M8.52M6.64M5.15M3.09M1.40M15.00M13.28M11.63M10.35M9.04M
Free Cash FlowFCF
-0.83M-3.50M-0.78M-1.20M-1.46M-2.00M-2.03M-2.61M-2.19M-2.85M-2.73M-1.81M-1.50M-2.05M-1.69M-1.41M-1.60M-1.65M-1.27M-1.31M
Net Cash FlowNCF
-0.83M16.68M-0.78M-1.20M-1.46M-2.00M4.67M-2.86M-2.19M-2.92M-2.73M-1.81M-1.50M-2.05M-1.69M-1.41M-1.72M-1.65M-1.27M-1.31M

Anebulo Pharmaceuticals Cash Flow Statement API

Pull Anebulo Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ANEB&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY